U.S. Leisure Stock News

Tempus AI, Inc., the Keck School of Medicine of USC, and Keck Medicine of USC recently launched a multi-faceted AI and data collaboration spanning more than 1.5 million annual patient visits across USC Norris Comprehensive Cancer Center, Keck Hospital of USC, USC Verdugo Hills, and affiliated Southern California clinics. This alliance not only embeds Tempus’ molecular diagnostics and clinical trial matching into USC’s workflows, but also creates a shared platform to co-develop AI tools that...

In recent days, BioNTech has come under pressure as investors reacted to possible U.S. pharmaceutical tariffs, leadership changes involving co-founders Ugur Sahin and Özlem Türeci, and uncertainty ahead of the May 5 earnings report, following the company’s earlier decision to lower its 2026 revenue guidance. This combination of policy risk, leadership transition, and reset expectations is prompting investors to reconsider how confidently they can assess BioNTech’s future direction. Next,...

In late April 2026, Generac Holdings Inc. reported first-quarter results showing sales of US$1,059.37 million and net income of US$73.25 million, and raised its full-year 2026 outlook to mid-to-high teens percent total net sales growth with an expected net income margin of about 8.0% to 9.0%. A key driver behind this updated guidance was strong commercial and industrial demand, particularly from data center customers, which also pushed the company’s backlog above US$700 million and...

Atlas Energy Solutions recently advanced construction of its long-haul proppant conveyor and completed a US$390 million private offering of 0.50% Convertible Senior Notes due 2031 to support its logistics and growth plans. These initiatives highlight Atlas’s push to modernize sand delivery for hydraulic fracturing while raising fresh capital amid questions over expenses, cash burn, and long-term profitability. We’ll now examine how the ambitious Dune Express conveyor project and related...

In April 2026, Biogen Inc. reported first-quarter 2026 results showing revenue of US$2.48 billion and net income of US$319.5 million, with earnings per share rising versus the prior year but accompanied by lower full-year guidance due to higher research and development spending and expected pressure on older multiple sclerosis drugs. Biogen also agreed to acquire TJ Biopharma’s Greater China rights to felzartamab for up to US$850 million, consolidating worldwide control of this late-stage...

In late April 2026, AXT, Inc. reported first-quarter 2026 results showing sales of US$26.92 million, a much smaller net loss of US$1.62 million, and the completion of a roughly US$550.00 million follow-on share offering to fund expansion of its semiconductor substrate operations. Beyond the headline growth, AXT highlighted surging demand and a record backlog for indium phosphide substrates used in AI-focused data centers, underlining its role in easing a key supply bottleneck for...

Valero Energy (VLO) has jumped onto investor watchlists after first quarter 2026 results showed sales of US$30,656 million and net income of US$1,263 million, compared with a net loss a year earlier. See our latest analysis for Valero Energy. That earnings rebound and dividend increase have come alongside a strong run in the shares, with a 36.98% 90 day share price return and a 1 year total shareholder return of 113.68% pointing to building momentum around Valero’s cash generation story. If...

In April 2026, Xerox Holdings reported first‑quarter 2026 revenue of US$1.85 billion, up from US$1.46 billion a year earlier, while its net loss widened to US$105 million and loss per share from continuing operations increased to US$0.84. A few days earlier, Xerox also launched its AI-powered “Xerox IT as a Service” platform built on ServiceNow, underscoring its push to evolve from legacy print hardware into a services-led, IT and automation provider for small and mid-sized businesses. Next,...

On 20 April 2026, Arcus Biosciences and Gilead Sciences discontinued the Phase 3 STAR-121 and Phase 2 EDGE-Lung studies in metastatic non-small cell lung cancer after an Independent Data Monitoring Committee deemed the domvanalimab plus zimberelimab and chemotherapy arm futile, while zimberelimab plus chemotherapy showed overall survival in line with pembrolizumab plus chemotherapy. Arcus also disclosed that Gilead will let certain option rights lapse in July 2026, narrowing access to...

ASA Gold and Precious Metals Limited recently renewed its authorization to repurchase up to 5% of its common shares through April 30, 2027, allowing opportunistic buybacks when the fund trades at a discount to net asset value. This move comes as trading models highlight weak near-term sentiment and stress-tested support levels, underscoring how capital management and technical signals intersect for this specialized precious-metals fund. With recent share price declines and a renewed buyback...

Exponent, Inc. reported past first-quarter 2026 results with sales of US$151.82 million, total revenue of US$166.3 million, and net income of US$29.57 million, alongside basic and diluted EPS of US$0.59 from continuing operations and a quarterly dividend of US$0.31 per share. The company paired this earnings strength with maintained high-single-digit revenue growth guidance, leadership changes, and an expanded share repurchase authorization, highlighting management’s focus on long-term...

First Industrial Realty Trust, Inc. recently reported first-quarter 2026 results showing higher sales of US$194.83 million and net income of US$143.10 million, and the board declared a US$0.5000 quarterly dividend payable on July 20, 2026 to shareholders of record on June 30, 2026. The company also issued full-year 2026 net income guidance of US$2.32 to US$2.42 per share, giving investors a clearer view of expected profitability alongside the confirmed dividend payout. We’ll now examine how...

Enviri at a glance Enviri (NVRI) has attracted investor attention recently after posting annual revenue of US$2.24b alongside a net loss of US$163.54 million. This has prompted closer scrutiny of its environmental services and rail operations. See our latest analysis for Enviri. At a share price of US$19.66, Enviri’s 1 year total shareholder return of 178.08% and 3 year total shareholder return of 114.86% indicate strong recent momentum, supported by a 9.83% year to date share price...

Reinsurance Group of America, Incorporated recently announced it will redeem in full on June 15, 2026, all of its outstanding US$400 million 5.75% Fixed-to-Floating Rate Subordinated Debentures due 2056 at par plus accrued interest, after which interest on these securities will stop accruing. This move marks a meaningful capital structure adjustment, signaling a shift in how the company manages long-dated subordinated debt within its broader financing mix. We’ll now examine how this full...

In late April 2026, Enterprise Products Partners L.P. reported first-quarter 2026 results showing sales of US$14.39 billion versus US$15.42 billion a year earlier, with net income rising to US$1.48 billion and diluted earnings per share from continuing operations increasing to US$0.68 from US$0.64. Beyond the headline figures, management linked record operating volumes and higher export demand to newly commissioned assets and raised growth capital spending plans for 2026, tying current...

Carlyle Group (CG) shares attracted fresh attention after the firm expanded its partnership with SEI, a move aimed at widening access to institutional-quality private market solutions for wealth and retirement investors. See our latest analysis for Carlyle Group. The strengthened SEI partnership has arrived at a time when Carlyle’s share price has shown a 6.21% 1 month share price return but remains lower over the year to date, while multi year total shareholder returns above 100% point to...

Bank of N.T. Butterfield & Son reported first-quarter 2026 results showing higher net interest income of US$93.28 million and net income of US$62.62 million, with earnings per share rising versus the prior year, while also affirming a quarterly dividend of US$0.50 per share and completing a 800,000-share buyback for US$42.40 million. Alongside these stronger earnings, the completed acquisition of Rollinson and Hunter Guernsey expands Butterfield’s private trust footprint, potentially...

Why Green Plains Is In Focus Ahead of Earnings Green Plains (GPRE) has moved into the spotlight as investors weigh an upcoming earnings release, elevated short interest, and fresh insider equity activity, all of which are shaping expectations and perceived risk around the stock. See our latest analysis for Green Plains. At a share price of $17.76, Green Plains has seen a 52.58% 90 day share price return and a very large 1 year total shareholder return, while the 5 year total shareholder...

In late April 2026, Hims & Hers Health announced that director candidates Christiane Pendarvis and Dr. Pat Carroll would not stand for re-election at the 2026 annual meeting, reducing the board to nine members while Dr. Carroll remains Global Chief Medical Officer. This board reshaping comes as the company faces fresh class action lawsuits over data security and rising competition in GLP-1 weight-loss telehealth, putting additional focus on governance and oversight. Next, we’ll examine how...

Understanding the recent move in Resolute Holdings Management stock Resolute Holdings Management (RHLD) has drawn attention after a period of mixed share performance, including a 10.38% decline over the past month and a 31.01% decline over the past 3 months, prompting closer inspection from investors. See our latest analysis for Resolute Holdings Management. At a share price of $138.38, RHLD sits well below its recent 90 day share price return of a 31.01% decline, even as its 1 year total...

Pagaya Technologies recently reported mixed Q4 2025 results, modestly missing revenue and adjusted EBITDA expectations while delivering record GAAP net income and emphasizing tighter risk management and long-term stability. A subsequent amendment to its 2025 annual report detailed how strong revenue of US$1.30 billion, GAAP net income of US$81.00 million and Adjusted EBITDA of US$371.00 million fed directly into a performance-heavy executive pay structure and refreshed governance...

First quarter results and buyback activity reset the picture for M/I Homes stock M/I Homes (MHO) recently reported first quarter results showing year on year declines in revenue and net income, alongside ongoing share repurchases that reduced the share count by 2.27% under its authorized buyback. See our latest analysis for M/I Homes. Despite the softer first quarter and recent buyback update, investors have seen a 17.7% total shareholder return over the past year and a 93.1% total...

Recent trading in Gorman-Rupp (GRC) has drawn attention after the stock’s one-month return of 21.8% and three-month return of 35.1%, prompting investors to reassess the pump manufacturer’s current valuation and fundamentals. See our latest analysis for Gorman-Rupp. Zooming out beyond the recent surge, Gorman-Rupp’s 30-day share price return of 21.8% and year-to-date share price return of 58.2%, alongside a 1-year total shareholder return of 110.0%, indicate momentum backed by reinvested...

U.S. Bancorp (USB) is back in focus after recent share price moves, with the stock closing at $56.30. Investors are weighing that level against the bank’s earnings profile, dividends and perceived longer term value. See our latest analysis for U.S. Bancorp. Against a 41.5% 1 year total shareholder return and a 110.6% 3 year total shareholder return, the recent 6.3% 1 month share price return indicates momentum has been building again despite some softer 90 day share price performance. If U.S...